588 related articles for article (PubMed ID: 27492861)
1. Negative control of TRAIL-R1 signaling by transforming growth factor β1 in pancreatic tumor cells involves Smad-dependent down regulation of TRAIL-R1.
Radke DI; Ungefroren H; Helm O; Voigt S; Alp G; Braun H; Hübner S; Dilchert J; Sebens S; Adam D; Kalthoff H; Trauzold A
Cell Signal; 2016 Nov; 28(11):1652-62. PubMed ID: 27492861
[TBL] [Abstract][Full Text] [Related]
2. Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function.
Schniewind B; Groth S; Sebens Müerköster S; Sipos B; Schäfer H; Kalthoff H; Fändrich F; Ungefroren H
Oncogene; 2007 Jul; 26(33):4850-62. PubMed ID: 17297450
[TBL] [Abstract][Full Text] [Related]
3. Nuclear death receptor TRAIL-R2 inhibits maturation of let-7 and promotes proliferation of pancreatic and other tumor cells.
Haselmann V; Kurz A; Bertsch U; Hübner S; Olempska-Müller M; Fritsch J; Häsler R; Pickl A; Fritsche H; Annewanter F; Engler C; Fleig B; Bernt A; Röder C; Schmidt H; Gelhaus C; Hauser C; Egberts JH; Heneweer C; Rohde AM; Böger C; Knippschild U; Röcken C; Adam D; Walczak H; Schütze S; Janssen O; Wulczyn FG; Wajant H; Kalthoff H; Trauzold A
Gastroenterology; 2014 Jan; 146(1):278-90. PubMed ID: 24120475
[TBL] [Abstract][Full Text] [Related]
4. Proteinase-activated receptor 2 promotes TGF-β-dependent cell motility in pancreatic cancer cells by sustaining expression of the TGF-β type I receptor ALK5.
Zeeh F; Witte D; Gädeken T; Rauch BH; Grage-Griebenow E; Leinung N; Fromm SJ; Stölting S; Mihara K; Kaufmann R; Settmacher U; Lehnert H; Hollenberg MD; Ungefroren H
Oncotarget; 2016 Jul; 7(27):41095-41109. PubMed ID: 27248167
[TBL] [Abstract][Full Text] [Related]
5. TRAIL-induced expression of uPA and IL-8 strongly enhanced by overexpression of TRAF2 and Bcl-xL in pancreatic ductal adenocarcinoma cells.
Zhou DH; Yang LN; Roder C; Kalthoff H; Trauzold A
Hepatobiliary Pancreat Dis Int; 2013 Feb; 12(1):94-8. PubMed ID: 23392805
[TBL] [Abstract][Full Text] [Related]
6. The anti-oxidative transcription factor Nuclear factor E2 related factor-2 (Nrf2) counteracts TGF-β1 mediated growth inhibition of pancreatic ductal epithelial cells -Nrf2 as determinant of pro-tumorigenic functions of TGF-β1.
Genrich G; Kruppa M; Lenk L; Helm O; Broich A; Freitag-Wolf S; Röcken C; Sipos B; Schäfer H; Sebens S
BMC Cancer; 2016 Feb; 16():155. PubMed ID: 26915435
[TBL] [Abstract][Full Text] [Related]
7. Stem cell marker nestin is critical for TGF-β1-mediated tumor progression in pancreatic cancer.
Su HT; Weng CC; Hsiao PJ; Chen LH; Kuo TL; Chen YW; Kuo KK; Cheng KH
Mol Cancer Res; 2013 Jul; 11(7):768-79. PubMed ID: 23552743
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers of TGF-β signaling pathway and prognosis of pancreatic cancer.
Javle M; Li Y; Tan D; Dong X; Chang P; Kar S; Li D
PLoS One; 2014; 9(1):e85942. PubMed ID: 24465802
[TBL] [Abstract][Full Text] [Related]
9. Aberrant NFATc1 signaling counteracts TGFβ-mediated growth arrest and apoptosis induction in pancreatic cancer progression.
Hasselluhn MC; Schmidt GE; Ellenrieder V; Johnsen SA; Hessmann E
Cell Death Dis; 2019 Jun; 10(6):446. PubMed ID: 31171768
[TBL] [Abstract][Full Text] [Related]
10. Dasatinib blocks transcriptional and promigratory responses to transforming growth factor-beta in pancreatic adenocarcinoma cells through inhibition of Smad signalling: implications for in vivo mode of action.
Bartscht T; Rosien B; Rades D; Kaufmann R; Biersack H; Lehnert H; Gieseler F; Ungefroren H
Mol Cancer; 2015 Nov; 14():199. PubMed ID: 26588899
[TBL] [Abstract][Full Text] [Related]
11. Cytoplasmic TRAIL-R1 is a positive prognostic marker in PDAC.
Gundlach JP; Hauser C; Schlegel FM; Böger C; Röder C; Röcken C; Becker T; Egberts JH; Kalthoff H; Trauzold A
BMC Cancer; 2018 Jul; 18(1):777. PubMed ID: 30064384
[TBL] [Abstract][Full Text] [Related]
12. Insights Into SMAD4 Loss in Pancreatic Cancer From Inducible Restoration of TGF-β Signaling.
Fullerton PT; Creighton CJ; Matzuk MM
Mol Endocrinol; 2015 Oct; 29(10):1440-53. PubMed ID: 26284758
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor β receptor signaling restrains growth of pancreatic carcinoma cells.
Zhao Z; Xi H; Xu D; Li C
Tumour Biol; 2015 Sep; 36(10):7711-6. PubMed ID: 25934336
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of TRAIL-Receptor 1 Increases TGFβ Type II Receptor Expression and TGFβ Signalling Via MicroRNA-370-3p in Pancreatic Cancer Cells.
Radke DI; Ling Q; Häsler R; Alp G; Ungefroren H; Trauzold A
Cancers (Basel); 2018 Oct; 10(11):. PubMed ID: 30366420
[TBL] [Abstract][Full Text] [Related]
15. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
[TBL] [Abstract][Full Text] [Related]
16. TGFB1-induced autophagy affects the pattern of pancreatic cancer progression in distinct ways depending on SMAD4 status.
Liang C; Xu J; Meng Q; Zhang B; Liu J; Hua J; Zhang Y; Shi S; Yu X
Autophagy; 2020 Mar; 16(3):486-500. PubMed ID: 31177911
[TBL] [Abstract][Full Text] [Related]
17. TGFbeta1 represses proliferation of pancreatic carcinoma cells which correlates with Smad4-independent inhibition of ERK activation.
Giehl K; Seidel B; Gierschik P; Adler G; Menke A
Oncogene; 2000 Sep; 19(39):4531-41. PubMed ID: 11002426
[TBL] [Abstract][Full Text] [Related]
18. Restoration of Smad4 in BxPC3 pancreatic cancer cells attenuates proliferation without altering angiogenesis.
Yasutome M; Gunn J; Korc M
Clin Exp Metastasis; 2005; 22(6):461-73. PubMed ID: 16320109
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of LINC01638 lncRNA inhibits migration and invasion of pancreatic ductal adenocarcinoma cells by reducing TGF‑β signaling.
Lu H; Ye J; Zhang L; Li M; Lu S; Yang D; Hu W
Mol Med Rep; 2019 Nov; 20(5):4533-4539. PubMed ID: 31702018
[TBL] [Abstract][Full Text] [Related]
20. The transcription factor GLI1 interacts with SMAD proteins to modulate transforming growth factor β-induced gene expression in a p300/CREB-binding protein-associated factor (PCAF)-dependent manner.
Nye MD; Almada LL; Fernandez-Barrena MG; Marks DL; Elsawa SF; Vrabel A; Tolosa EJ; Ellenrieder V; Fernandez-Zapico ME
J Biol Chem; 2014 May; 289(22):15495-506. PubMed ID: 24739390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
